vision

Health Tech By Casey Ross

Google develops AI to identify patients at high risk of blindness

In the Lab By Associated Press

In its first use inside the human body, CRISPR genome editing tested as blindness therapy

Pharmalot By Ed Silverman

Novartis employee claims she was fired for complaining about incorrect data

Biotech By Matthew Herper

Safety concerns regarding Novartis’ new eye drug boost Regeneron stock

In the Lab By Orly Nadell Farber

Glaucoma may be an autoimmune disease, study finds, suggesting new treatment approaches

In the Lab By Andrew Joseph

Early trials of stem-cell therapies hint at potential to restore some vision

Biotech By Andrew Joseph

At $850,000, price for new childhood blindness gene therapy four times too high, analysis says

Health By Rebecca Robbins

‘What the 21st century demands’: designing homes to improve patients’ health

Health By Leah Samuel

5 beauty-enhancing gadgets throughout history that were terrible ideas

Health By Charles Piller

Google Glass is back — as a tool to coach autistic children, train doctors, and more

Boddities By Megan Thielking

Watch: Episode 12: What would happen to your eyes if you looked at the solar eclipse?

Medical Mystery By Allison Bond

This 6-year-old suddenly had trouble reading. Why was she going blind?

Boddities By Megan Thielking

How well do you know your body? Take our quiz

Medical Mystery By Allison Bond

When eye irritation is more than it seems at first glance

In the Lab By Andrew Joseph

Q&A: Turning to stem cells to restore vision

In the Lab By Eric Boodman

Transplanted eyes let tadpoles see through their tails

Health By Sharon Begley

Three patients blinded by stem cell procedure, physicians say

Health By Associated Press

New help for that bane of middle age: blurry close-up vision

Business By Charles Piller

Autofocus contact lens being developed by Verily and Alcon suffers delay